Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Hiesse

Showing results (51-60 of 137) with videos related to

Pageof 14
Sort By:
Annales D'Urologie|January 1, 1986
[Malacoplakia and renal transplantation. Report of a case of testicular malacoplakia]G Benoit, P Icard, C Hiesse, et al.
Kidney International. Supplement|October 1, 1992
How to deal with the hyperimmunized potential recipientsB M Charpentier, C Hiesse, F Kriaa, et al.
Transplantation Proceedings|February 1, 1993
Effects of renal transplantation on apoproteins: decrease in the B/A1 ratio atherogenicity indexD Zucman, M Fénéant-Thibault, N Manceur, et al.
Annales De Pathologie|January 1, 1996
[Encrusted pyelo-ureteritis and cystitis by Corynebacterium D2 in a renal transplant]V Meignin, P Blanchet, J Quillard, et al.
Transplantation Proceedings|February 1, 1997
Lymphocytotoxic antibody responses to one prospective HLA-DR typed blood transfusion in naive patients awaiting renal transplantation. The Groupe Coopératif de Transplantation de l'Ile de FranceM Busson, C Hiesse, C Buisson, et al.
Transplantation Proceedings|March 26, 2004
Single-center experience with cyclosporine therapy for kidney transplantation: analysis of a twenty-year period in 1200 patientsR Snanoudj, F Kriaa, N Arzouk, et al.
Transplantation Proceedings|February 1, 1997
Malignancy after renal transplantation: analysis of incidence and risk factors in 1700 patients followed during a 25-year periodC Hiesse, P Rieu, F Kriaa, et al.
Transplantation|April 27, 1997
Cytotoxic T lymphocyte changes after HLA-DR match and HLA-DR mismatch blood transfusionsV Baudouin, N de Vitry, C Hiesse, et al.
Transplantation Proceedings|May 30, 2001
Overview of clinical trials with new agentsB Charpentier, C Hiesse, A Durrbach, et al.
Presse Medicale (Paris, France : 1983)|November 27, 1991
[Acute clinical syndrome associated with OKT3 administration. Prevention by single injection of an anti-human TNF monoclonal antibody]B Charpentier, C Hiesse, C Ferran, et al.
Pageof 14

Showing results (51-60 of 137) with videos related to

Sort By:
Pageof 14
Annales D'Urologie|January 1, 1986
[Malacoplakia and renal transplantation. Report of a case of testicular malacoplakia]G Benoit, P Icard, C Hiesse, et al.
Kidney International. Supplement|October 1, 1992
How to deal with the hyperimmunized potential recipientsB M Charpentier, C Hiesse, F Kriaa, et al.
Transplantation Proceedings|February 1, 1993
Effects of renal transplantation on apoproteins: decrease in the B/A1 ratio atherogenicity indexD Zucman, M Fénéant-Thibault, N Manceur, et al.
Annales De Pathologie|January 1, 1996
[Encrusted pyelo-ureteritis and cystitis by Corynebacterium D2 in a renal transplant]V Meignin, P Blanchet, J Quillard, et al.
Transplantation Proceedings|February 1, 1997
Lymphocytotoxic antibody responses to one prospective HLA-DR typed blood transfusion in naive patients awaiting renal transplantation. The Groupe Coopératif de Transplantation de l'Ile de FranceM Busson, C Hiesse, C Buisson, et al.
Transplantation Proceedings|March 26, 2004
Single-center experience with cyclosporine therapy for kidney transplantation: analysis of a twenty-year period in 1200 patientsR Snanoudj, F Kriaa, N Arzouk, et al.
Transplantation Proceedings|February 1, 1997
Malignancy after renal transplantation: analysis of incidence and risk factors in 1700 patients followed during a 25-year periodC Hiesse, P Rieu, F Kriaa, et al.
Transplantation|April 27, 1997
Cytotoxic T lymphocyte changes after HLA-DR match and HLA-DR mismatch blood transfusionsV Baudouin, N de Vitry, C Hiesse, et al.
Transplantation Proceedings|May 30, 2001
Overview of clinical trials with new agentsB Charpentier, C Hiesse, A Durrbach, et al.
Presse Medicale (Paris, France : 1983)|November 27, 1991
[Acute clinical syndrome associated with OKT3 administration. Prevention by single injection of an anti-human TNF monoclonal antibody]B Charpentier, C Hiesse, C Ferran, et al.
Pageof 14